Key Takeaways:
- Ekso Bionics (EKSO, Financial) initiates a 1-for-15 reverse stock split to boost its share price and comply with Nasdaq requirements.
- Wall Street analysts project an average price target of $2.50, suggesting significant potential upside.
- GuruFocus estimates a GF Value indicating a 171.9% upside, highlighting the stock's potential undervaluation.
Ekso Bionics Implements Reverse Stock Split
Ekso Bionics (NASDAQ: EKSO) announced an initiative to execute a 1-for-15 reverse stock split, effective May 27, 2025. This strategic move reduces the company's outstanding shares from approximately 35.29 million to 2.35 million. The primary goal is to enhance the stock price, thereby ensuring compliance with Nasdaq's listing standards. Following the announcement, the stock experienced a modest gain of 0.96%, trading at $0.3342 in after-hours sessions.
Wall Street Analysts Provide Optimistic Forecast
In analyzing the prospects of Ekso Bionics Holdings Inc (EKSO, Financial), two analysts have set a one-year average price target of $2.50. This target is accompanied by a high estimate of $4.00 and a low of $1.00. The projected average target suggests a remarkable upside of 655.29% from its current trading price of $0.33. For more detailed forecasts, investors can access the Ekso Bionics Holdings Inc (EKSO) Forecast page.
Brokerage Recommendation and GF Value Assessment
The consensus recommendation from two brokerage firms places Ekso Bionics Holdings Inc (EKSO, Financial) at an average rating of 2.0, categorizing it under the "Outperform" status. This rating operates on a scale from 1 to 5, where 1 represents a Strong Buy and 5 indicates a Sell.
According to GuruFocus estimates, the estimated GF Value for Ekso Bionics Holdings Inc (EKSO, Financial) in the upcoming year is projected at $0.90. This forecast suggests a potential upside of 171.9% from the current price of $0.331. The GF Value is a metric that approximates the fair trading value of the stock, derived from historical multiples, past growth figures, and future performance projections. For comprehensive data, visit the Ekso Bionics Holdings Inc (EKSO) Summary page.
Overall, these metrics and projections underscore an intriguing potential for growth, offering valuable insights for investors considering Ekso Bionics as part of their portfolio strategy.
